Adani Wilmar And Emcure Pharmaceuticals To Launch IPO

Adani Wilmar and Emcure Pharmaceuticals to launch IPO, know full details

Edible oil company Adani Wilmar’s initial public offering (IPO) of Rs 3,600 crore will open on January 27.

Drugmaker Emcure Pharmaceuticals will present its Rs 5,000 crore IPO next month i.e. in February.

Adani Wilmar, which sells cooking oil and some other food products under the Fortune brand, has reduced the size of its IPO to Rs 3,600, from Rs 4,500 crore earlier.

Adani Wilmar and Emcure Pharmaceuticals: Adani Wilmar is a 50:50 joint venture between the Adani Group and the Singapore-based Wilmar Group.

Adani Enterprises told the stock exchanges on Thursday that the company’s IPO will open for subscription on January 27 and close on January 31.

The same Emcure Pharmaceuticals has got the approval for the IPO documents (DRHP). The company will soon file RHP for an issue of Rs 5,000 crore.

According to merchant banking sources, the company will bring its IPO soon after the budget.

Under the company’s Rs 5,000 crore IPO, Rs 1,100 crore new shares will be issued. The balance will be in the form of Offer for Sale (OFS) by the promoter shareholders of the company.

Meanwhile, the initial public offering (IPO) of AGS Transact Technologies was subscribed 1.42x on the second day of the issue on Thursday.

As per data available on BSE, 2,86,74,696 shares of the company on offer received bids for 4,05,74,240 shares.

The Retail Individual Investor (RII) segment was subscribed 2.06 times, the non-institutional investor category 1.13 times.

The eligible institutional investor’s segment has got 49 percent subscription till the second day.

This is the first IPO of 2022. AGS Transact on Tuesday raised Rs 204 crore from anchor investors. This IPO of the company is purely in the form of an Offer for Sale (OFS).

Under this, the promoters and other shareholders of the company have offered shares worth Rs 680 crore. The price range for the IPO is Rs 166 to Rs 175 per share.